News

Japan´s foremost medical institute purchases multiple HoloMonitor instruments

Japan’s foremost medical research institute, The Institute of Medical Science at University of Tokyo, recently purchased two HoloMonitor M4. Together with RIKEN and Kyoto University, the institute spearheads Japan’s national effort to become the undisputed leader of regenerative medicine in the world.

Read More

EU grants 2.1 million euro to Phase Holographic Imaging and Malmö University with partners for joint cancer research

The European Commission has appointed Phase Holographic Imaging,Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer.

Read More

American association of cancer research highlights article published by PHI collaborators

In the October issue of Molecular Cancer Therapeutics the American Association of Cancer Research (AACR) highlights the novel nano­medicine against ovarian cancer developed by scientists from the Center for Pharma­ceutical Bio­tech­nology and Nano­medicine at North­eastern University.

Read More

Lab of Nobel Price winner purchases HoloMonitor

The Department of Optical Nanoscopy (Prof. Stefan W. Hell) at the German Cancer Research Center (DKFZ) in Heidelberg recently ordered a motorized HoloMonitor M4. Professor Hell was awarded the Nobel Prize in Chemistry in 2014 for his pioneering work in the field of super-resolution fluorescence microscopy.

Read More

PHI receives significant order

PHI has received a follow-up order for a minimum of eight motorized HoloMonitor M4 instruments, continuing the strong business performance in the Chinese market. The total customer list price of the ordered instruments amounts to 2.8 MSEK. The instruments will be delivered to PHI’s Chinese distributor during the coming 12 months on a continuous basis.

Read More

HoloMonitor technology facilitates cancer research at Florida International University

Prof. Roy flanked by Dr. Quentin Felty and Dr. Jayanta Das in front of their poster at AACR The first results of the ongoing collaboration between the Department of Environmental and Occupational at Florida International University (FIU) and PHI were presented in April at the annual meeting of the American Association for Cancer Research (AACR).

Read More

Nature publishes new HoloMonitor article, PHI achieves 50 publications

Researchers at Chinese Academy of Sciences have used HoloMonitor®technology from PHI to investigate cell behavior when Earth’s magnetic field is eliminated. The findings were recently published in Scientific Reports – an online journal published by Nature Publishing Group.

Read More

Cell laboratory at Japanese University orders third HoloMonitor

One of the cell laboratories at Kyushu University in Japan has ordered two HoloMonitor® instruments to complement the instrument previously purchased by the laboratory. The university is one of the seven imperial universities which today form Japan’s prestigious national universities.

Read More

Nature publish HoloMonitor Research

Cells cultivated on nanowires, imaged by HoloMonitor Researchers at Lund University have used Holo­Monitor® technology from Phase Holo­graphic Imaging to investi­gate the behavior of cells when culti­vated on nanowires. The findings were recently published in Scientific Reports – anonline journal published by Nature Publishing Group.

Read More

PHI and Boston Children’s Hospital enter evaluation agreement

PHI and Boston Children’s Hospital – a Harvard Medical School teaching hospital – have signed an agreement to evaluate PHI’s HoloMonitor®technology for applications in cell-based cancer research.

Read More